Prions form when a normal protein already present on the surface of brain cells physically refolds into an abnormal shape, and that misshapen copy then forces neighboring copies of the same protein to refold the same way. There is no virus, no bacterium, no DNA or RNA directing the process. The infectious agent is the misfolded protein itself, and its ability to recruit and convert normal protein molecules is what makes prion diseases both unique and difficult to treat. The structural switch at the heart of the process involves a dramatic rearrangement from a loosely coiled shape into flat, stacked sheets that clump together into insoluble aggregates.
The Normal Protein and What It Does
Every healthy mammalian brain produces a protein called PrPC (the “C” stands for cellular). It sits on the outer surface of neurons, tethered to the cell membrane by a small lipid anchor, and is found in especially high concentrations throughout the central nervous system. Despite decades of study, researchers still do not fully understand what PrPC does. The best-supported roles include helping maintain the insulating myelin sheaths around nerve fibers, regulating cell growth and adhesion, and influencing iron uptake into cells.1PubMed Central. Physiological Functions of the Cellular Prion Protein There are also hints that it participates in synaptic signaling, circadian rhythm, and immune function, but those connections are still being worked out. The point worth emphasizing is that PrPC is not a pathogen lurking in your brain. It is a routine protein doing routine work. The disease starts only when its shape changes.
What Changes During Misfolding
In its normal form, PrPC is mostly made up of alpha-helices, which are tightly wound coils. Spectroscopy measurements show that about 42% of the normal protein’s structure consists of alpha-helices, with virtually no beta-sheet content at all (around 3%).2PubMed Central. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins Beta-sheets are flat, ribbon-like arrangements where protein strands line up side by side and form hydrogen bonds between them. When PrPC misfolds into the disease-associated form, called PrPSc (the “Sc” comes from scrapie, the sheep disease where prions were first studied), the balance flips: the beta-sheet content jumps to roughly 43% while the alpha-helix drops to about 30%.2PubMed Central. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins
Hydrogen-deuterium exchange studies have mapped the region of the protein that forms the core of the misfolded structure. It corresponds to the tail end of the protein, starting at around residue 169, a stretch that in the normal protein encompasses two of its major alpha-helices and the loop between them.3PubMed Central. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange In other words, the very parts of PrPC that are coiled up neatly in health are the same regions that flatten out into beta-sheets in disease. This is not a small tweak; it is a wholesale architectural change in the protein’s backbone.
Why does this matter functionally? Beta-sheet-rich structures are sticky. They stack on top of one another, forming long fibers called amyloid. These fibers are extraordinarily stable, resistant to the enzymes that normally chop up and recycle damaged proteins, and they accumulate in brain tissue as insoluble plaques. The transformation from a soluble, flexible, helix-rich molecule into a rigid, sheet-rich aggregate is the central event in every prion disease.
How One Misfolded Copy Recruits the Next
The defining feature of prions is not just that the protein misfolds, but that the misfolded version acts as a template. When PrPSc encounters a normal PrPC molecule, it physically contacts it and induces it to refold into the same beta-sheet-rich shape. The newly converted copy can then do the same thing to yet another normal molecule, creating a chain reaction. This is what “protein-only” infectivity means: the misfolded structure itself carries the information needed to propagate, without any genetic material.4PubMed Central. Prion disease and the ‘protein-only hypothesis’
The idea was controversial for decades because it broke a basic rule of biology: infectious agents were supposed to carry nucleic acids. Key experiments showed otherwise. Researchers found that procedures that destroy DNA and RNA, including massive doses of ionizing radiation and ultraviolet light, did not eliminate infectivity. Meanwhile, anything that destroyed protein structure did reduce infectivity, and anti-PrP antibodies could neutralize it.5Trends in Biochemical Sciences. How are prions formed? The misfolded process explained These results, accumulated over years, built the case that the protein alone is the infectious agent.
In laboratory settings, the conversion process can be influenced by conditions like salt concentration and denaturants that destabilize the protein’s normal fold. The rate at which alpha-helical PrP transitions to a beta-sheet-rich oligomeric form depends strongly on these environmental stresses.6PubMed. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein Inside the body, the conversion is thought to happen primarily within the endocytic compartment, the internal vesicles that cells use to recycle membrane proteins. PrPC normally cycles between the cell surface and these internal compartments, and it appears that contact with PrPSc during this recycling trip is where the conversion takes place.
Cofactors That Grease the Wheels
The “protein-only” label can be misleading if you take it too literally. While PrPSc is the infectious agent, other molecules in the cellular environment play important supporting roles. Experiments using a technique called protein misfolding cyclic amplification (PMCA) have shown that lipids and RNA can facilitate the spontaneous refolding of PrP into an infectious conformation, even without any pre-existing PrPSc seed to start the process.7PubMed Central. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity That finding was striking because it suggested the first misfolded molecule in a sporadic case might arise spontaneously if the right cofactors are present.
Cofactors do more than help get things started. When researchers removed cofactor molecules during serial propagation of purified prions, the resulting PrPSc could still self-replicate in a test tube but lost its infectivity by more than a hundred-thousand-fold.8PubMed Central. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions Even more remarkably, swapping one cofactor for another during propagation changed the strain properties of the resulting prion, including its structure and the disease pattern it caused. A single lipid cofactor, phosphatidylethanolamine, could force three distinct prion strains to converge into one new strain with its own unique characteristics.8PubMed Central. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions So cofactors are not just passive bystanders. They actively shape which conformation the misfolded protein adopts and whether that conformation is truly infectious.
How Genetic Mutations Tip the Balance
Most human prion disease cases are sporadic, meaning no known trigger. A smaller fraction are inherited, caused by mutations in the gene that encodes PrP. Researchers have studied how disease-linked amino acid substitutions affect the protein’s stability. Mutations in the hydrophobic core of PrP have a significant destabilizing effect, increasing the protein’s tendency to unfold and misfold, which helps explain their role in familial prion diseases.9PubMed Central. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding
The picture is not as neat as “mutation destabilizes protein, protein misfolds, disease follows.” Studies measuring the thermodynamic stability of PrP variants carrying different inherited mutations found that only some of the disease-associated substitutions actually destabilize the protein. Others leave stability unchanged compared to the normal version.10PubMed. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein That means destabilization is one route to misfolding but not the only one. Some mutations may instead change how PrPC interacts with cofactors, chaperone proteins, or PrPSc seeds, rather than simply making the protein more floppy.
Species Barriers and Why Prions Don’t Jump Freely Between Animals
If prion propagation is purely about shape, you might expect any PrPSc to convert any PrPC regardless of species. In practice, transmission between species is limited by what is called the species barrier. The barrier arises from differences in the amino acid sequence of PrP between species: even small sequence mismatches can prevent the misfolded template from accurately imposing its structure on a foreign PrP molecule.11PubMed. Species-barrier-independent prion replication in apparently resistant species
Work with recombinant PrP has shown that substituting a single amino acid in a critical region can completely change the seeding specificity of prion fibrils. But barriers are not absolute walls. When cross-species transmission does occur despite a high barrier, the resulting prion often emerges as a new strain with altered properties. The template essentially adapts by selecting for a conformation that the host protein can accommodate, giving rise to prion variants with different incubation times and disease profiles.12PubMed. Molecular basis of barriers for interspecies transmissibility of mammalian prions This is why prion strain diversity exists at all: the same protein sequence can be folded into multiple distinct misfolded conformations, each of which behaves like a different pathogen.13PubMed Central. Prion variants, species barriers, generation and propagation
Why Prion Diseases Are So Damaging to the Brain
The accumulation of PrPSc aggregates in brain tissue triggers a cascade of harmful effects. These include the characteristic sponge-like holes (spongiform degeneration) visible under a microscope, disruption of synaptic connections, inflammation driven by the brain’s own immune cells, and outright neuronal death.14PubMed Central. The intricate mechanisms of neurodegeneration in prion diseases These processes operate simultaneously and reinforce each other, which is part of the reason prion diseases progress so relentlessly once symptoms appear. Losing PrPC‘s normal functions, including its roles in myelin maintenance and synaptic health, likely compounds the damage caused by the toxic aggregates themselves.
Environmental Persistence
Because PrPSc aggregates lack the fragile features of conventional pathogens (no lipid envelope, no nucleic acid genome to damage), they are extraordinarily tough. Prions resist ultraviolet and ionizing radiation, survive exposure to proteases and standard chemical disinfectants, and withstand heat treatments that would destroy virtually any virus or bacterium.15PubMed Central. Fate of Prions in Soil: A Review When shed into the environment, prions bind tightly to soil particles, especially clay minerals like montmorillonite, and such binding can actually increase oral disease transmission rather than neutralizing the protein.16PubMed. Chemical Inactivation of Prions Is Altered by Binding to the Soil Mineral Montmorillonite Prions can remain infectious in soil for years, which is a serious concern for managing diseases like chronic wasting disease in deer and elk, where contaminated pastures can continue to infect new animals long after sick ones are removed.17PubMed Central. Prions in the environment: occurrence, fate and mitigation
Turning Misfolding into a Diagnostic Tool
The same self-templating behavior that makes prions dangerous has been harnessed for diagnosis. A technique called RT-QuIC (real-time quaking-induced conversion) takes advantage of the fact that even tiny amounts of PrPSc in a patient’s cerebrospinal fluid can seed the conversion of normal recombinant PrP in a test tube. The growing aggregates are detected in real time using a fluorescent dye that lights up when it binds to amyloid fibers.18PubMed Central. Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease For sporadic Creutzfeldt-Jakob disease, the most common human prion disease, RT-QuIC performed on cerebrospinal fluid currently achieves a sensitivity of about 92% and a specificity of 100%.19Practical Neurology. RT-QuIC: a new test for sporadic CJD That combination means virtually no false positives and very few missed cases, a dramatic improvement over earlier diagnostic methods that relied on brain biopsy or post-mortem examination.
Researchers have also adapted the assay for blood-based detection. An optimized version using iron oxide magnetic extraction was able to identify samples from sheep infected with bovine spongiform encephalopathy at both clinical and preclinical stages, detecting infection up to two years before symptoms appeared.20PLoS ONE. How Are Prions Formed? The Misfolding Process Explained If similar approaches prove reliable for human blood screening, it could transform how prion diseases are caught and how blood supplies are safeguarded.
Therapeutic Strategies Under Development
There are currently no approved treatments that halt or reverse prion disease in humans. But the misfolding process itself offers several points of attack. Strategies being explored include preventing PrPC from reaching the cell surface where it encounters PrPSc, using chemical chaperones to lock PrPC in its normal fold so it cannot be converted, and blocking the direct interaction between PrPC and PrPSc.21Biosafety and Health. Therapeutic implications of prion diseases
One approach that reached human testing involves an antibody designed to bind and stabilize PrPC in its normal alpha-helical conformation. The logic is straightforward: PrPC has to unfold before it can refold into the beta-sheet-rich form, so if an antibody is sitting on the folded protein, it acts like a physical lock holding the normal shape in place. A humanized monoclonal antibody called PRN100 was developed for exactly this purpose and entered a first-in-human safety trial in patients with Creutzfeldt-Jakob disease.22The Lancet. First-in-human treatment of Creutzfeldt-Jakob disease with humanised anti-prion protein monoclonal antibody PRN100: a safety and biomarker study The trial was primarily about safety, not efficacy, and the field is still far from a proven therapy. But the fact that the misfolding mechanism can be targeted at all gives researchers a framework for future drug development.
Prion-Like Behavior in Alzheimer’s, Parkinson’s, and Other Diseases
The prion concept has expanded well beyond the classic prion diseases. Proteins central to Alzheimer’s (amyloid-beta and tau) and Parkinson’s (alpha-synuclein) also misfold, aggregate, and spread through the brain in patterns that look strikingly similar to prion propagation. Growing evidence suggests that misfolded alpha-synuclein can be taken up by neurons and trigger the conversion of normal alpha-synuclein molecules inside those cells, templating the misfolded conformation in a prion-like chain reaction.23PubMed Central. The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses Whether this constitutes true prion-like transmission or something more limited is a major area of research.24PubMed Central. Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils
The distinction matters. Classic prions are infectious between individuals and can cross species. The misfolded proteins in Alzheimer’s and Parkinson’s appear to spread within a single brain along neural pathways, but there is no convincing evidence they pass from person to person under normal circumstances. Still, the shared mechanism of templated misfolding is real, and researchers studying these common neurodegenerative diseases are borrowing diagnostic and therapeutic strategies straight from the prion field, including RT-QuIC-style seeding assays now being developed for alpha-synuclein detection.
When Prion-Like Folding Is Actually Useful
Not every self-templating protein fold is harmful. Biology has apparently found uses for the prion mechanism. In the nervous system, a protein called CPEB (cytoplasmic polyadenylation element-binding protein) has a prion-like state that appears to help stabilize long-term memories. The idea is that a self-sustaining conformational switch, one that does not require the original signal to remain present, is a good way to store a lasting change at a synapse.25PubMed Central. The Role of Functional Prion-Like Proteins in the Persistence of Memory Yeast also harbor several well-characterized prion-like proteins that regulate gene expression and metabolic adaptation through self-perpetuating conformational changes.26PubMed. Prions: what are they good for?
These functional prion-like proteins share the core trick of disease prions (a protein conformational switch that propagates itself) but without the toxicity. They tend to form small, controlled aggregates rather than the massive, insoluble plaques that destroy tissue. Their existence suggests that the prion mechanism is not inherently pathological. It is a molecular strategy for creating stable, self-renewing signals. Disease prions represent what happens when that strategy runs off the rails in a protein whose aggregated form happens to be both toxic and uncontrollable by the cell’s normal quality-control machinery.